Targeted next-generation sequencing (NGS) enables the identification of genomic variants
in cancer patients with high sensitivity at relatively low costs, and has thus opened the era to …

T-cell lymphoma (TCL) is an uncommon and aggressive form of human cancer. Lymphoma
is the most common hematopoietic tumor in canines (companion animals), with TCL …

Abstract NanoString's nCounter Analysis System performs a highly multiplexed, digital
quantification of up to 800 genes in a single reaction. This is achieved via reporter three …

Lymphoma (lymphosarcoma) is the second most frequent cancer in dogs and is clinically
comparable to human non-Hodgkin lymphoma. Factors affecting canine lymphoma …

Canine cancer, a significant cause of mortality in domestic dogs, is a powerful comparative
model for human cancers. Revealing genetic alterations driving the oncogenesis of canine …

In dogs as well as humans, lymphoma is one of the most common hematopoietic
malignancies. Furthermore, due to its characteristics, canine lymphoma is recognized as a …

A genomic understanding of the oncogenic processes and individual variability of human
cancer has steadily fueled improvement in patient outcomes over the past 20 years …

Objectives Canine lymphoma, the most common hematological cancer in dogs, shares
many molecular and clinical characteristics with human Non-Hodgkin lymphoma (NHL). The …

Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of lymphoma in dogs
with a multicentric form. This study aimed to assemble 41 variants of the previously reported …

The genomic landscape in human B-cell lymphoma has revealed several somatic mutations
and potentially relevant germline alterations affecting therapy and prognosis. Also …